Search filters

List of works by Aranzazu Fernandez-Martinez

Clinical implications of the intrinsic molecular subtypes of breast cancer

scientific article

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer.

scientific article

Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer.

scientific article published on 28 August 2017

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy

scientific article published on 25 February 2021

Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma.

scientific article published on September 2016

Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis.

scientific article published on 8 February 2016

Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer

scientific article

Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients

scientific article

Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab.

scientific article

Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer

scientific article published on 02 November 2015

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

scientific article

Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma

scientific article

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

scientific article published on 23 October 2020